← Every applicant
Amneal Pharms FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LACOSAMIDENew drugMar 27, 2024SOLUTION, ORAL |
| CARBAMAZEPINENew drugSep 22, 2023TABLET, EXTENDED RELEASE, ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDENew drugAug 11, 2023TABLET, ORAL |
| VIGABATRINNew drugJun 22, 2022TABLET, ORAL |
| ESTRADIOL AND PROGESTERONENew drugMay 16, 2022CAPSULE, ORAL |
| SUCRALFATENew drugApr 15, 2022TABLET, ORAL |
| LACOSAMIDENew drugMar 17, 2022TABLET, ORAL |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATENew drugJul 20, 2021CAPSULE, ORAL |